Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenSubsidies
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • WarCosts
  • OpenPrescriber
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Pneumococcal (Prevnar13)
  4. Cardiac monitoring
Pneumococcal (Prevnar13)×Cardiac monitoring

Cardiac monitoring Reports for Pneumococcal (Prevnar13)

#707 most reported symptom for this vaccine

16
Reports
1
Deaths
14
Hospitalizations
6.25
Mortality Rate
%
87.5
Hosp. Rate
%

Cardiac monitoring and Pneumococcal (Prevnar13)

Cardiac monitoring has been reported 16 times in association with Pneumococcal (Prevnar13) vaccination in VAERS. This represents 0.0% of all 33,058 reports for this vaccine.

Among these reports, 1 mentioned death (6.25%) and 14 involved hospitalization (87.5%).

Cardiac monitoring is the #707 most frequently reported symptom for Pneumococcal (Prevnar13) out of 1920 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 16 reports of Cardiac monitoring after Pneumococcal (Prevnar13) vaccination may seem alarming, but context is critical.

The 6.25% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.

Important Context

•Association, not causation: These reports show Cardiac monitoring occurred after vaccination, not that the vaccine caused it.
•Background rates: Cardiac monitoring may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Oral administration complication16 reportsBlood magnesium normal16 reportsHot flush16 reportsBlood bilirubin normal16 reports

Quick Facts

Reports:16
Deaths:1
Hospitalizations:14
% of Vaccine:0.0%
Rank:#707 of 1920

Related Pages

Pneumococcal (Prevnar13) OverviewCardiac monitoring (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.